Go Pro

Warby Parker (WRBY) Competitors

Warby Parker logo
$27.47 -1.58 (-5.44%)
Closing price 07/13/2026 03:59 PM Eastern
Extended Trading
$27.40 -0.07 (-0.25%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

WRBY vs. PEN, GKOS, LQDA, BLCO, and STVN

Should you buy Warby Parker stock or one of its competitors? MarketBeat compares Warby Parker with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Warby Parker include Penumbra (PEN), Glaukos (GKOS), Liquidia (LQDA), Bausch + Lomb (BLCO), and Stevanato Group (STVN). These companies are all part of the "medical equipment" industry.

How does Warby Parker compare to Penumbra?

Penumbra (NYSE:PEN) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment and earnings.

In the previous week, Penumbra had 1 more articles in the media than Warby Parker. MarketBeat recorded 5 mentions for Penumbra and 4 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.41 beat Penumbra's score of 0.00 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Penumbra presently has a consensus target price of $360.33, suggesting a potential upside of 13.09%. Warby Parker has a consensus target price of $29.82, suggesting a potential upside of 8.55%. Given Penumbra's higher possible upside, equities analysts plainly believe Penumbra is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
1 Sell rating(s)
14 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.11
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67

Penumbra has higher revenue and earnings than Warby Parker. Penumbra is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$1.45B8.62$177.69M$4.3473.41
Warby Parker$871.91M3.37$1.64M$0.021,373.45

88.9% of Penumbra shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Comparatively, 16.8% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Penumbra has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Penumbra's return on equity of 10.87% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra11.76% 10.87% 8.45%
Warby Parker 0.15%2.30%1.18%

Penumbra has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market.

Summary

Penumbra beats Warby Parker on 9 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Glaukos?

Warby Parker (NYSE:WRBY) and Glaukos (NYSE:GKOS) are both mid-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Warby Parker presently has a consensus price target of $29.82, indicating a potential upside of 8.55%. Glaukos has a consensus price target of $151.77, indicating a potential downside of 0.65%. Given Warby Parker's higher probable upside, research analysts plainly believe Warby Parker is more favorable than Glaukos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67
Glaukos
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80

In the previous week, Glaukos had 7 more articles in the media than Warby Parker. MarketBeat recorded 11 mentions for Glaukos and 4 mentions for Warby Parker. Glaukos' average media sentiment score of 0.65 beat Warby Parker's score of 0.41 indicating that Glaukos is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Glaukos
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 99.0% of Glaukos shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by insiders. Comparatively, 5.9% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Warby Parker has a beta of 1.91, meaning that its stock price is 91% more volatile than the broader market. Comparatively, Glaukos has a beta of 0.75, meaning that its stock price is 25% less volatile than the broader market.

Warby Parker has higher revenue and earnings than Glaukos. Glaukos is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M3.37$1.64M$0.021,373.45
Glaukos$551.35M16.27-$187.69M-$3.28N/A

Warby Parker has a net margin of 0.15% compared to Glaukos' net margin of -34.34%. Warby Parker's return on equity of 2.30% beat Glaukos' return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Glaukos -34.34%-6.92%-5.25%

Summary

Warby Parker beats Glaukos on 10 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Liquidia?

Warby Parker (NYSE:WRBY) and Liquidia (NASDAQ:LQDA) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Warby Parker has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market. Comparatively, Liquidia has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market.

Warby Parker has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M3.37$1.64M$0.021,373.45
Liquidia$158.32M40.00-$68.92M$0.14508.64

93.2% of Warby Parker shares are held by institutional investors. Comparatively, 64.5% of Liquidia shares are held by institutional investors. 16.8% of Warby Parker shares are held by company insiders. Comparatively, 25.6% of Liquidia shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Liquidia had 7 more articles in the media than Warby Parker. MarketBeat recorded 11 mentions for Liquidia and 4 mentions for Warby Parker. Liquidia's average media sentiment score of 0.54 beat Warby Parker's score of 0.41 indicating that Liquidia is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Liquidia
5 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker currently has a consensus target price of $29.82, suggesting a potential upside of 8.55%. Liquidia has a consensus target price of $68.88, suggesting a potential downside of 3.28%. Given Warby Parker's higher probable upside, equities analysts plainly believe Warby Parker is more favorable than Liquidia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67
Liquidia
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
3 Strong Buy rating(s)
2.82

Liquidia has a net margin of 7.74% compared to Warby Parker's net margin of 0.15%. Liquidia's return on equity of 46.82% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Liquidia 7.74%46.82%7.06%

Summary

Liquidia beats Warby Parker on 10 of the 17 factors compared between the two stocks.

How does Warby Parker compare to Bausch + Lomb?

Warby Parker (NYSE:WRBY) and Bausch + Lomb (NYSE:BLCO) are both mid-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

93.2% of Warby Parker shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 16.8% of Warby Parker shares are held by insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Warby Parker has a net margin of 0.15% compared to Bausch + Lomb's net margin of -4.21%. Bausch + Lomb's return on equity of 3.60% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Bausch + Lomb -4.21%3.60%1.69%

Warby Parker has a beta of 1.91, indicating that its stock price is 91% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

Warby Parker has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M3.37$1.64M$0.021,373.45
Bausch + Lomb$5.10B1.14-$360M-$0.62N/A

In the previous week, Bausch + Lomb had 3 more articles in the media than Warby Parker. MarketBeat recorded 7 mentions for Bausch + Lomb and 4 mentions for Warby Parker. Bausch + Lomb's average media sentiment score of 0.56 beat Warby Parker's score of 0.41 indicating that Bausch + Lomb is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bausch + Lomb
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker currently has a consensus price target of $29.82, suggesting a potential upside of 8.55%. Bausch + Lomb has a consensus price target of $18.00, suggesting a potential upside of 10.77%. Given Bausch + Lomb's higher probable upside, analysts plainly believe Bausch + Lomb is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67
Bausch + Lomb
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.21

Summary

Warby Parker beats Bausch + Lomb on 10 of the 16 factors compared between the two stocks.

How does Warby Parker compare to Stevanato Group?

Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Stevanato Group has higher revenue and earnings than Warby Parker. Stevanato Group is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$871.91M3.37$1.64M$0.021,373.45
Stevanato Group€1.34B4.46€158.21M€0.5933.52

In the previous week, Warby Parker had 3 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Warby Parker and 1 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.73 beat Warby Parker's score of 0.41 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

93.2% of Warby Parker shares are held by institutional investors. 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Warby Parker presently has a consensus target price of $29.82, suggesting a potential upside of 8.55%. Given Warby Parker's higher possible upside, equities analysts clearly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.67
Stevanato Group
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
2.83

Stevanato Group has a net margin of 11.76% compared to Warby Parker's net margin of 0.15%. Stevanato Group's return on equity of 10.27% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Stevanato Group 11.76%10.27%6.08%

Warby Parker has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Summary

Stevanato Group beats Warby Parker on 10 of the 17 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerCONS PD IndustryStaples SectorNYSE Exchange
Market Cap$3.11B$30.64B$16.39B$23.46B
Dividend YieldN/A3.22%3.33%4.02%
P/E Ratio1,374.1475.9726.3931.08
Price / Sales3.371.6144.2019.77
Price / Cash46.1713.6313.3718.64
Price / Book7.8911.155.984.77
Net Income$1.64M$1.30B$668.93M$1.06B
7 Day Performance-2.15%-3.30%-1.50%-0.23%
1 Month Performance4.35%-1.42%-2.46%-0.11%
1 Year Performance19.35%-15.20%-13.17%16.46%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
2.8697 of 5 stars
$27.47
-5.4%
$29.82
+8.6%
+23.7%$3.11B$871.91M1,374.144,036
PEN
Penumbra
1.6267 of 5 stars
$318.11
-0.1%
$360.33
+13.3%
+34.2%$12.53B$1.40B73.304,700
GKOS
Glaukos
1.6838 of 5 stars
$148.66
+0.2%
$150.62
+1.3%
+47.3%$8.71B$507.44MN/A1,094
LQDA
Liquidia
2.6567 of 5 stars
$79.21
+0.4%
$68.88
-13.0%
+405.4%$7.02B$158.32M565.8350
BLCO
Bausch + Lomb
3.7159 of 5 stars
$17.10
-0.4%
$17.83
+4.3%
+17.1%$6.13B$5.10BN/A13,000

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners